“Screening for Breast Cancer with Mammography” (2013), by Peter Gøtzsche and Karsten Jørgensen

“Screening for Breast Cancer with Mammography” (2013), by Peter Gøtzsche and Karsten Jørgensen “Screening for Breast Cancer with Mammography” is a Cochrane systematic review originally published by Peter Gøtzsche and Karsten Jørgensen in 2001 and updated multiple times by 2013. In the 2013 article, the authors discuss the reliability of the results from different clinical trials involving mammography and provide their conclusions about whether mammography screening is useful in preventing deaths from breast cancer. Mammography is an X-ray technique used to detect abnormalities in breast tissue, such as breast cancer, which affects about twelve percent of women in the world and has a significant risk of mortality. The authors concluded that mammography screenings reduced breast cancer mortality, but resulted in problems such as

HIP Randomized Breast Cancer Screening Trial (1963–1982)

HIP Randomized Breast Cancer Screening Trial (1963–1982)From 1963 to 1982, researchers in New York City, New York, carried out a randomized trial of mammography screening. Mammography is the use of X-ray technology to find breast cancer at early stages. The private insurance company Health Insurance Plan of Greater New York, or HIP, collaborated with researchers Sam Shapiro, Philip Strax, and Louis Venet on the trial. The researchers’ goal was to determine whether mammography screening reduced breast cancer mortality in women. The study included sixty thousand women aged forty to sixty-four. Half of the women received two annual breast examinations that involved mammography, a breast exam, and an interview. The rest of the women were not invited for annual examinations. After follow up, the researchers found that of

“Maternal and Perinatal Outcomes Associated with a Trial of Labor after Prior Cesarean Delivery” (2004), Mark B. Landon et al.

“Maternal and Perinatal Outcomes Associated with a Trial of Labor after Prior Cesarean Delivery” (2004), Mark B. Landon, John C. Hauth, Kenneth J. Leveno, Catherine Y. Spong, Sharon Leindecker, Michael W. Varner, Atef H. Moawad, Steve N. Caritis, Margaret Harper, Ronald J. Wapner, Yoram Sorokin, Menachem Miodovnik, Marshall Carpenter, Alan M. Peaceman, Mary Jo O'Sullivan, Baha Sibai, Oded Langer, John M. Thorp, Susan M. Ramin, Brian M. Mercer, and Steven G. GabbeIn 2004 Mark Landon and his colleagues in the United States published “Maternal and Perinatal Outcomes Associated with a Trial of Labor after Prior Cesarean Delivery,” which compared the risks of vaginal delivery and cesarean section for delivery of a fetus after a previous cesarean delivery.

“Infant Survival After Cesarean Section for Trauma” (1996), by John A. Morris, Jr. et al.

“Infant Survival After Cesarean Section for Trauma” (1996), by John A. Morris, Jr., Todd J. Rosenbower, Gregory J. Jurkovich, David B. Hoyt, J. Duncan Harviel, M. Margaret Knudson, Richard S. Miller, Jon M. Burch, J. Wayne Meredith, Steven E. Ross, Judith M. Jenkins, and John G. Bass

"Risks and Benefits of Estrogen Plus Progestin in Healthy, Postmenopausal Women: Principal Results from the Women's Health Initiative Randomized Controlled Trial" (2002), by Jacques Rossouw et al.

"Risks and Benefits of Estrogen Plus Progestin in Healthy, Postmenopausal Women: Principal Results from the Women's Health Initiative Randomized Controlled Trial" (2002), by Jacques Rossouw, Garnet Anderson, Ross Prentice, Andrea LaCroix, Charles Kooperberg, Marcia Stefanick, Rebecca Jackson, Shirley Beresford, Barbara Howard, Karen Johnson, Jane Morley Kotchen, and Judith OckeneIn 2002, the Writing Group for the Women's Health Initiative Investigators published the article "Risks and Benefits of Estrogen Plus Progestin in Healthy, Postmenopausal Women: Principal Results from the Women's Health Initiative Randomized Controlled Trial" in The Journal of the American Medical Association. In the article, the authors report on the Women's Health Initiative, which was a study initiated by the

The Development of Mifepristone for Use in Medication Abortions

The Development of Mifepristone for Use in Medication AbortionsIn the 1980s, researchers at the pharmaceutical company Roussel-Uclaf in Paris, France, helped develop a biological compound called mifepristone. When a woman takes it, mifepristone interferes with the function of hormones involved in pregnancy and it can therefore be used to terminate pregnancies. In 2000, the US Food and Drug Administration approved mifepristone, also called RU 486, as part of a treatment to induce abortions using drugs instead of surgery, a method called medication abortion.

The Jane Collective (1969–1973)

The Jane Collective (1969–1973) The Jane Collective was an underground organization that provided illegal abortion services in Chicago, Illinois, from 1969 until abortions became legal in 1973. Formally called the Abortion Counseling Service of Women’s Liberation, the Jane Collective was a member organization and working group within Chicago Women’s Liberation Union that challenged the Illinois state legislature by providing abortions before they were legal in the US.

Elizabeth Dexter Hay (1927–2007)

Elizabeth Dexter Hay (1927–2007) Elizabeth Dexter Hay studied the cellular processes that affect development of embryos in the US during the mid-twentieth and early twenty-first centuries. In 1974, Hay showed that the extracellular matrix, a collection of structural molecules that surround cells, influences cell behavior. Cell growth, cell migration, and gene expression are influenced by the interaction between cells and their extracellular matrix. Hay also discovered a phenomenon later called epithelial-mesenchymal transition, a process that occurs during normal embryo and adult development in which epithelial cells, cells that line external and internal surfaces of the body, transform into

"The Contagiousness of Puerperal Fever” (1843), by Oliver Wendell Holmes

“The Contagiousness of Puerperal Fever” (1843), by <a href="/search?text=Oliver%20Wendell%20Holmes" title="" class="lexicon-term">Oliver Wendell Holmes</a> In 1843, physician Oliver Wendell Holmes wrote and published "The Contagiousness of Puerperal Fever," an essay about puerperal fever, a disease that occurs mainly as a result of bacterial infection in the uterine tract of women after giving birth or undergoing an abortion. In the essay, Holmes argues that puerperal fever is spread through birth attendants like physicians and midwives who make contact with the disease and carry it from patient to patient. The article was published in The New England Quarterly Journal of Medicine and Surgery in 1843.

"National Institutes of Health Consensus Development Conference Statement September 22–24, 1980” (1980), by the National Institutes of Health

"National Institutes of Health Consensus Development Conference Statement September 22–24, 1980” (1980), by the National Institutes of Health"In 1980 the US National Institutes of Health (NIH) and the US National Institute of Child Health and Human Development (NICHD) released a report titled, “National Institutes of Health Consensus Development Conference Statement September 22–24, 1980.” The report lists recommendations for birth delivery through cesarean sections, a surgical procedure used to deliver the fetus via the pregnant woman’s abdomen. The recommendations arose from the 1980 Consensus Development Conference on Cesarean Childbirth in Bethesda, Maryland.